Skip to content

Benchmark Survey on Psoriasis and PsA 2002

Benchmark Survey on Psoriasis and PsA 2002 1

10. doi: 10.1111/jdv.13150. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey. To obtain real-world physician perspectives on the impact of psoriasis and PsA and its treatment on patients’ daily lives, including perceptions of, and satisfaction with, current therapies. 799 patients (469 with RA, 164 with AS, 65 with axial PsA and 101 with peripheral PsA) accepted the invitation to participate. Rheumatology (Oxford) 2002;41 Suppl 1:36. In this article, we discuss the impact of psoriasis and PsA on patients’ HRQOL by examining the effects of these conditions on patients’ functional capabilities and on their psychosocial well-being. Large-scale European Survey of Quality of Life in Patients with Psoriasis: Second-phase results on quality of life and treatment reported by 7,575 members of European psoriasis patient associations.

Benchmark Survey on Psoriasis and PsA 2002 2The PASI-75 is the currently recognized benchmark of end points used in psoriasis clinical trials. Learn about Psoriatic Arthritis symptoms, diagnosis, treatments, living well with psoriatic arthritis and how to find a doctor. Psoriatic arthritis (PsA) is a serious illness that has a similar impact on quality of life to that of rheumatoid arthritis (RA), another inflammatory arthritis. Benchmark survey on psoriasis and psoriatic arthritis.

Jama Network

Benchmark Survey on Psoriasis and PsA 2002 3

Physician Perspectives In The Management Of Psoriasis And Psoriatic Arthritis: Results From The Population-based Multinational Assessment Of Psoria